Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Greenacre and Pecora elected to NeoStem board

This article was originally published in Scrip

Executive Summary

NeoStem, a leader in the development and manufacture of cell therapies, has appointed Martyn Greenacre and Dr Andrew Pecora to its board. Mr Greenacre was previously chair of BMP Sunstone's board, and also served as a director of Cephalon. He is currently chair of the board of Acusphere and a director of Curis. From 1997 to 2001, Mr Greenacre was CEO and director of Delsys Pharmaceutical Corporation. Dr Pecora is co-founder and past chairman and CEO of PCT, now a NeoStem company. He currently serves as CMO of NeoStem, vice-president of cancer services and chief innovations officer of the John Theurer Cancer Center at Hackensack University Medical Center, and co-managing partner of the Northern Jersey Cancer Center.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC015560

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel